EUS-CPN With and Without Bupivacaine

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

February 28, 2027

Study Completion Date

December 31, 2027

Conditions
Pancreatic Cancer
Interventions
PROCEDURE

EUS-CPN without bupivacaine

Under conscious sedation, an echoendoscope is advanced into the stomach, just distal to the gastro-esophageal junction. The region of the celiac plexus is identified around the takeoff of the celiac artery from the aorta. Then, under real-time ultrasound guidance, a 19g needle is used to inject a neurolytic agent such as absolute alcohol around the base of the celiac artery.

PROCEDURE

EUS-CPN with bupivacaine

Under conscious sedation, an echoendoscope is advanced into the stomach, just distal to the gastro-esophageal junction. The region of the celiac plexus is identified around the takeoff of the celiac artery from the aorta. Then, under real-time ultrasound guidance, a 19g needle is used to firstly inject bupivacaine and secondly a neurolytic agent such as absolute alcohol around the base of the celiac artery.

Trial Locations (1)

H2X 0A9

RECRUITING

Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER